Jonathan Schechter has bought stock on 2 days since Sep 2025
Director at PharmaCyte Biotech, Inc., and 1 other company
SEC CIK 0001619259 · Filings on SEC.gov ↗
Jonathan Schechter's record
3 months after each buy, from the first price a copier could get.
1 buy has 3 months of prices so far. A record shows here at 3.
Companies
Every filing
2 filings since Sep 2025, newest first
About Jonathan Schechter
Jonathan L. Schechter is a seasoned finance and corporate governance professional serving as an Independent Director at PharmaCyte Biotech, Inc. (PMCB) since August 2022, where he has engaged in recent insider trading activity, including holdings of 50,000 shares as of July 2024.( He currently holds multiple board positions, including Chairman of Oblong, Inc. since 2024, Director at Neurotrope, Inc. and Synaptogenix, Inc. since 2018, and Partner at The Special Equities Group LLC since 2021 and Special Equities Opportunity Fund LLC since 2019.(
Schechter's career highlights include prior roles as Director at WPCS International, Inc., Director-Investment Banking at Chardan Capital Markets LLC, Independent Director at Atrinsic, Inc. (2014-2016), Director at DropCar Operating Co., Inc., and Associate at Bryan Cave Leighton Paisner LLP.( He earned an undergraduate degree from Duke University in 1995 and a graduate degree from Fordham University School of Law.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.